Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1188320180120050555
Gut and Liver
2018 Volume.12 No. 5 p.555 ~ p.561
Measuring Intrahepatic Vascular Changes Using Contrast-Enhanced Ultrasonography to Predict the Prognosis of Alcoholic Hepatitis Combined with Cirrhosis: A Prospective Pilot Study
Park Min-Sun

Hong Soon-Chang
Lim Yoo-Li
Kang Seong-Hee
Baik Soon-Koo
Kim Moon-Young
Abstract
Background/Aims: Acute hepatic dysfunction combined with alcoholic hepatitis (AH) in alcoholic cirrhosis is related to hepatic hypo-perfusion secondary to intrahepatic necroinflammation, neoangiogenesis, and shunt. The hepatic vein arrival time (HVAT) assessed by microbubble contrast enhanced ultrasonography (CEUS) is closely correlated with the severity of intrahepatic changes. We investigated the usefulness of HVAT to predict short-term mortality of AH in cirrhosis.

Methods: Thirty-nine patients with alcoholic cirrhosis (27 males) and AH were prospectively enrolled. HVAT study was performed within 3 days after admission using ultrasonic contrast (SonoVue¢ç). The primary outcome was 12-week mortality.

Results: Twelve-week mortality developed in nine patients. HVAT was significantly different between the mortality and survival groups (9.3¡¾2.0 seconds vs 12.6¡¾3.5 seconds, p=0.002). The odds ratio of a shortened HVAT for 12-week mortality was 1.481 (95% confidence interval, 1.050?2.090; p=0.025). The area under the receiver operating characteristic curve of HVAT for 12-week mortality was 0.787 (p=0.010). The combination of MDF and HVAT ¡Ã11.0 seconds resulted in an 87.5% survival rate even if the MDF score ¡Ã32; however, HVAT £¼11.0 seconds was related with mortality despite a MDF score£¼32.

Conclusions: HVAT using microbubble CEUS could be a useful additional index to predict short-term mortality in patients with AH and cirrhosis.
KEYWORD
Hepatitis, alcoholic, Liver cirrhosis, alcoholic, Hepatic veins, Ultrasonography, contrast-enhanced
FullTexts / Linksout information
 
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed